Time‐Varying Clearance and Impact of Disease State on the Pharmacokinetics of Avelumab in Merkel Cell Carcinoma and Urothelial Carcinoma

Time‐Varying Clearance and Impact of Disease State on the Pharmacokinetics of Avelumab in Merkel Cell Carcinoma and Urothelial Carcinoma

Avelumab, a human anti–programmed death ligand 1 immunoglobulin G1 antibody, has shown efficacy and manageable safety in multiple tumors. A two‐compartment population pharmacokinetic model for avelumab incorporating intrinsic and extrinsic covariates and time‐varying clearance (CL) was identified ba...

Full description

Bibliographic Details
Main Authors:	Justin J. Wilkins, Brigitte Brockhaus, Haiqing Dai, Yulia Vugmeyster, Joleen T. White, Satjit Brar, Carlo L. Bello, Berend Neuteboom, Janet R. Wade, Pascal Girard, Akash Khandelwal
Format:	Article
Language:	English
Published:	Wiley 2019-06-01
Series:	CPT: Pharmacometrics & Systems Pharmacology
Online Access:	https://doi.org/10.1002/psp4.12406

Similar Items

Avelumab for the treatment of patients with Merkel cell carcinoma
by: K. V. Orlova, et al.
Published: (2020-07-01)

Immunotherapy in Merkel cell carcinoma: role of Avelumab
by: Palla AR, et al.
Published: (2018-03-01)

Avelumab for advanced Merkel cell carcinoma in the Netherlands: a real-world cohort
by: Dirk Grünhagen, et al.
Published: (2020-07-01)

Hematological Toxicity During Concomitant Treatment With Ruxolitinib and Avelumab for Merkel Cell Carcinoma
by: Luciana Buonerba, et al.
Published: (2020-10-01)

Budget impact model of avelumab in patients with metastatic merkel cell carcinoma in the US
by: Bharmal M, et al.
Published: (2019-05-01)

Hypercalcaemia due to Sarcoidosis during Treatment with Avelumab for Metastatic Merkel Cell Carcinoma
by: Sandy Tun Min, et al.
Published: (2019-08-01)

Complete response to avelumab and IL-15 superagonist N-803 with Abraxane in Merkel cell carcinoma: a case study
by: Leylah Drusbosky, et al.
Published: (2020-07-01)

Avelumab treatment in Italian patients with metastatic Merkel cell carcinoma: experience from an expanded access program
by: Giovanni Grignani, et al.
Published: (2021-02-01)

Favorable Response to Treatment with Avelumab in an HIV-Positive Patient with Advanced Merkel Cell Carcinoma Previously Refractory to Chemotherapy
by: Mohammed U. Al Homsi, et al.
Published: (2018-07-01)

Case Report: Clinical Experience With Avelumab in Patients With Metastatic Merkel Cell Carcinoma and Brain Metastases Treated in Europe
by: Kate Fife, et al.
Published: (2021-05-01)

First-line avelumab in a cohort of 116 patients with metastatic Merkel cell carcinoma (JAVELIN Merkel 200): primary and biomarker analyses of a phase II study
by: Jessica C Hassel, et al.
Published: (2021-07-01)

Efficacy and safety of avelumab treatment in patients with metastatic Merkel cell carcinoma: experience from a global expanded access program
by: Luc Dirix, et al.
Published: (2020-06-01)

Avelumab in patients with previously treated metastatic Merkel cell carcinoma: long-term data and biomarker analyses from the single-arm phase 2 JAVELIN Merkel 200 trial
by: Janice M Mehnert, et al.
Published: (2020-06-01)

Diffuse lichen planus-like keratoses and clinical pseudo-progression associated with avelumab treatment for Merkel cell carcinoma, a case report
by: Michael A. Cardis, et al.
Published: (2019-06-01)

265 Phase 1b study of avelumab + M9241 (NHS-IL12) in patients with advanced solid tumors: interim analysis results from a urothelial carcinoma (UC) dose-expansion cohort
by: Luc Dirix, et al.
Published: (2020-11-01)

Updated efficacy of avelumab in patients with previously treated metastatic Merkel cell carcinoma after ≥1 year of follow-up: JAVELIN Merkel 200, a phase 2 clinical trial
by: Howard L. Kaufman, et al.
Published: (2018-01-01)

Case Report: Exceptional Response to Avelumab After Failure of Electrochemotherapy in a Patient With Rapidly Progressive, PD-L1-Negative Merkel Cell Carcinoma
by: Martina Torchio, et al.
Published: (2021-06-01)

Merkel Cell Polyomavirus and Merkel Cell Carcinoma
by: Valeria Pietropaolo, et al.
Published: (2020-07-01)

Merkel Cell Carcinoma
by: Elena Dellambra, et al.
Published: (2021-06-01)

Merkel cell carcinoma
by: Koljonen Virve
Published: (2006-02-01)

Merkel Cell Polyomavirus and Merkel Cell Carcinoma, France
by: Vincent Foulongne, et al.
Published: (2008-09-01)

Histogenesis of Merkel cell carcinoma
by: Kervarrec, Thibault
Published: (2020)

Merkel Cell Polyomavirus Strains in Patients with Merkel Cell Carcinoma
by: Antoine Touzé, et al.
Published: (2009-06-01)

Merkel cell polyomavirus in Merkel cell carcinoma of Italian patients
by: Migliano Emilia, et al.
Published: (2011-03-01)

Merkel Cell Polyomavirus DNA in Persons without Merkel Cell Carcinoma
by: Ulrike Wieland, et al.
Published: (2009-09-01)

From Merkel Cell Polyomavirus Infection to Merkel Cell Carcinoma Oncogenesis
by: Nathan A. Krump, et al.
Published: (2021-09-01)

Avelumab as second-line therapy for metastatic, platinum-treated urothelial carcinoma in the phase Ib JAVELIN Solid Tumor study: 2-year updated efficacy and safety analysis
by: Keun-Wook Lee, et al.
Published: (2020-07-01)

Urothelial Carcinoma
by: Nan-Haw Chow, et al.
Published: (2012-01-01)

Carcinoma de Células de Merkel
by: Ana Cristina Gonçalves Castro
Published: (2019)

Awareness for Merkel Cell Carcinoma: Consider it
by: Bruno de Sousa Pina, et al.
Published: (2017-01-01)

Neuroendocrine (Merkel cell) carcinoma of the auricle
by: Divani Smaroula, et al.
Published: (2004-01-01)

An Unusual Presentation of Merkel Cell Carcinoma
by: Kamuran İbiş, et al.
Published: (2012-03-01)

Merkel Cell Carcinoma: An Update and Immunotherapy
by: Hiroshi Uchi
Published: (2018-03-01)

Merkel cell carcinoma of the abdominal wall
by: Vandana L Gaopande, et al.
Published: (2015-01-01)

AWARENESS FOR MERKEL CELL CARCINOMA: CONSIDER IT
by: Bruno Pina
Published: (2017-09-01)

Mutational Analysis of Merkel Cell Carcinoma
by: Derek J. Erstad, et al.
Published: (2014-10-01)

Imaging in Patients with Merkel Cell Carcinoma
by: Elisabeth Enzenhofer, et al.
Published: (2013-01-01)

Merkel Cell Carcinoma in Immunosuppressed Patients
by: Janice E. Ma, et al.
Published: (2014-06-01)

Merkel Cell Carcinoma: New Trends
by: Ellen M. Zwijnenburg, et al.
Published: (2021-03-01)

Molecular Profiling of Merkel Cell Polyomavirus-Associated Merkel Cell Carcinoma and Cutaneous Melanoma
by: Attila Mokánszki, et al.
Published: (2021-02-01)